The Doctoral Program ION CHANNELS AND TRANSPORTERS AS MOLECULAR DRUG TARGETS („MolTag“)
is pleased to invite you to the following ONLINE lecture
"Computational Methods for Active Compound Design and Risk Assessment”
by Ass.Prof.Dr. Andrea VOLKAMER
Institute of Physiology, Charité Universitätsmedizin Berlin
on: Tuesday, January 26, 2021, 16:00.
Host: Prof. Dr. Gerhard ECKER, UniVie
Please join our meeting from your computer, tablet or smartphone.
https://www.gotomeet.me/MolTagDoctoralProgram/guest-lecture-prof-andrea-volkamer
New to GoToMeeting? Get the app now and be ready when your first meeting starts: https://global.gotomeeting.com/install/113468573
ABSTRACT: Due to the ever-growing amount of available structural protein and compound data - from experimental sources or modeling approaches - computational methods to collect the data and put it to practical use are becoming more and more important. Thus, learning from the large pool of available data and using this knowledge for in silico predictions is of high practical value. In this presentation, structural bioinformatics and cheminformatics methods will be introduced which can be applied in translational projects to guide the design of more active, selective and/or less toxic compounds.
Professional Career Andrea Volkamer:
July 2016 – Present; Charité Berlin, Assistant professor; Field of research: In-silico toxicology predictions and structural bioinformatics
Sept 2013 – June 2016; BioMed X GmbH, Heidelberg: PostDoc Researcher; Field of research: Selective kinase inhibitor design
Feb 2013 – Aug 2013; University of Hamburg, Center for Bioinformatics, Pro Exzellenzia PostDoc Fellow in the group of Prof. Dr. Matthias Rarey
June 2008 – Sept 2012; University of Hamburg, Center for Bioinformatics, group of Prof. Dr. Matthias Rarey; Research scientist and coordinator of the project "COMPASITES: Computeraided active site analysis of protein structures". The project was part of the Biocatalysis 2021 cluster, funded by the BMBF with the industrial cooperation partners Merck KGaA, Darmstadt, and BioSolveIT GmbH.
April 2007 – May 2008: Purdue University (West Lafayette, USA), Scientific Researcher/Visiting Scholar in the group of Assistant Prof. Markus Lill, Ph.D.
Education: University of Hamburg Dr. rer. nat., Computational Biology (2008 - 2013), Universität des Saarlandes M.Sc., Bioinformatik (2005 – 2007)
For publications see: ORCID
